APP and APLP2 interact with the synaptic release machinery and facilitate transmitter release at hippocampal synapses
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
The amyloid precursor protein (APP), whose mutations cause familial Alzheimer’s disease, interacts with the synaptic release machinery, suggesting a role in neurotransmission. Here we mapped this interaction to the NH2-terminal region of the APP intracellular domain. A peptide encompassing this binding domain -named JCasp- is naturally produced by a γ-secretase/caspase double-cut of APP. JCasp interferes with the APP-presynaptic proteins interaction and, if linked to a cell-penetrating peptide, reduces glutamate release in acute hippocampal slices from wild-type but not APP deficient mice, indicating that JCasp inhibits APP function.The APP-like protein-2 (APLP2) also binds the synaptic release machinery. Deletion of APP and APLP2 produces synaptic deficits similar to those caused by JCasp. Our data support the notion that APP and APLP2 facilitate transmitter release, likely through the interaction with the neurotransmitter release machinery. Given the link of APP to Alzheimer’s disease, alterations of this synaptic role of APP could contribute to dementia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: APP binds DR6 to trigger axon pruning and neuron death via distinct caspases
Nikolaev, A., McLaughlin, T., O’Leary, D. D. M., & Tessier-Lavigne, M. (2009) · Nature · doi:10.1038/nature07767 · Cited by 992
RetractedVassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876 · cited 1×
“C83/a-CTF is cleaved by the g-secretase to produce a short peptide comprising the COOH-terminus of Ab, called P3, and AID/AICD (Annaert et al., 2000, De Strooper, 2003, Selkoe and Kopan, 2003, Sisodia and St George-Hyslop, 2002, Vassar et al., 1999).”
BackgroundMolecular mechanism and physiological functions of clathrin-mediated endocytosis
McMahon, H. T., & Boucrot, E. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3151 · Cited by 2,223
A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline
Jonsson, T., Atwal, J. K., Steinberg, S., Snaedal, J., Jonsson, P. V., Bjornsson, S., Stefansson, H., Sulem, P., Gudbjartsson, D., Maloney, J., et al. (2012) · Nature · doi:10.1038/nature11283 · Cited by 1,738 · cited 2×
“In humans, a polymorphism in APP that reduces APP processing protects from sporadic Alzheimer’s disease (AD) and normal aging-dependent cognitive decline (De Strooper and Voet, 2012, Jonsson et al., 2012).”
BackgroundMethodShankar, G. M., Bloodgood, B. L., Townsend, M., Walsh, D. M., Selkoe, D. J., & Sabatini, B. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4970-06.2007 · Cited by 1,592 · cited 2×
“…mediator of AD pathogenesis, have suggested that early pathogenic changes in AD were driven by postsynaptic impairments (Cissé et al., 2011, Ferreira et al., 2012, Li et al., 2009, Mucke and Selkoe, 2012, Parameshwaran et al., 2008, Roberson et al., 2011, Shankar et al., 2007, Um et al., 2012).”
BackgroundSüdhof, T. C. (2012) · Neuron · doi:10.1016/j.neuron.2012.06.012 · Cited by 1,251
Neurotransmitter Release: The Last Millisecond in the Life of a Synaptic Vesicle
Südhof, T. C. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.022 · Cited by 1,197
AMPAR Removal Underlies Aβ-Induced Synaptic Depression and Dendritic Spine Loss
Hsieh, H., Boehm, J., Sato, C., Iwatsubo, T., Tomita, T., Sisodia, S., & Malinow, R. (2006) · Neuron · doi:10.1016/j.neuron.2006.10.035 · Cited by 1,042
Neurotoxicity of Amyloid -Protein: Synaptic and Network Dysfunction
Mucke, L., & Selkoe, D. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006338 · Cited by 1,000 · cited 1×
“…mediator of AD pathogenesis, have suggested that early pathogenic changes in AD were driven by postsynaptic impairments (Cissé et al., 2011, Ferreira et al., 2012, Li et al., 2009, Mucke and Selkoe, 2012, Parameshwaran et al., 2008, Roberson et al., 2011, Shankar et al., 2007, Um et al., 2012).”
BackgroundAph-1, Pen-2, and Nicastrin with Presenilin Generate an Active γ-Secretase Complex
De Strooper, B. (2003) · Neuron · doi:10.1016/s0896-6273(03)00205-8 · Cited by 965 · cited 1×
“C83/a-CTF is cleaved by the g-secretase to produce a short peptide comprising the COOH-terminus of Ab, called P3, and AID/AICD (Annaert et al., 2000, De Strooper, 2003, Selkoe and Kopan, 2003, Sisodia and St George-Hyslop, 2002, Vassar et al., 1999).”
The secretases: enzymes with therapeutic potential in Alzheimer disease
De Strooper, B., Vassar, R., & Golde, T. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.218 · Cited by 799
Composition of isolated synaptic boutons reveals the amounts of vesicle trafficking proteins
Wilhelm, B. G., Mandad, S., Truckenbrodt, S., Kröhnert, K., Schäfer, C., Rammner, B., Koo, S. J., Claßen, G. A., Krauss, M., Haucke, V., et al. (2014) · Science · doi:10.1126/science.1252884 · Cited by 770
Picomolar Amyloid-β Positively Modulates Synaptic Plasticity and Memory in Hippocampus
Puzzo, D., Privitera, L., Leznik, E., Fà, M., Staniszewski, A., Palmeri, A., & Arancio, O. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2692-08.2008 · Cited by 740 · cited 1×
“…regulates normal synaptic transmission and prompts deficits in synaptic plasticity (Fogel et al., 2014, Mota et al., 2014, Puzzo and Arancio, 2013, Puzzo et al., 2008, Shankar et al., 2007, Sivanesan et al., 2013, Um et al., 2012). sAPPa has neurotrophic functions and is involved in synaptic…”
BackgroundThe genetics of Alzheimer disease
Tanzi, R. E. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006296 · Cited by 727
Roberson, E. D., Halabisky, B., Yoo, J. W., Yao, J., Chin, J., Yan, F., Wu, T., Hamto, P., Devidze, N., Yu, G.-Q., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.4152-10.2011 · Cited by 654 · cited 1×
“…mediator of AD pathogenesis, have suggested that early pathogenic changes in AD were driven by postsynaptic impairments (Cissé et al., 2011, Ferreira et al., 2012, Li et al., 2009, Mucke and Selkoe, 2012, Parameshwaran et al., 2008, Roberson et al., 2011, Shankar et al., 2007, Um et al., 2012).”
Backgroundγ-Secretase, notch, Aβ and alzheimer's disease: Where do the presenilins fit in?
Sisodia, S. S., & St George-Hyslop, P. H. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn785 · Cited by 512
A stop-codon mutation in the BRI gene associated with familial British dementia
Vidal, R., Frangione, B., Rostagno, A., Mead, S., Révész, T., Plant, G., & Ghiso, J. (1999) · Nature · doi:10.1038/21637 · Cited by 466 · cited 1×
“…familial AD (FAD) and the AD-like familial British dementia and familial Danish dementia (De Strooper, 2007, De Strooper et al., 2010, De Strooper and Voet, 2012, Garringer et al., 2010, Matsuda et al., 2005, Giliberto et al., 2008, Matsuda et al., 2009, Tanzi, 2012, Vidal et al., 1999, 2000).”
BackgroundReversing EphB2 depletion rescues cognitive functions in Alzheimer model
Cissé, M., Halabisky, B., Harris, J., Devidze, N., Dubal, D. B., Sun, B., Orr, A., Lotz, G., Kim, D. H., Hamto, P., et al. (2011) · Nature · doi:10.1038/nature09635 · Cited by 433 · cited 1×
“…and is considered the main mediator of AD pathogenesis, have suggested that early pathogenic changes in AD were driven by postsynaptic impairments (Cissé et al., 2011, Ferreira et al., 2012, Li et al., 2009, Mucke and Selkoe, 2012, Parameshwaran et al., 2008, Roberson et al., 2011, Shankar et…”
Backgroundη-Secretase processing of APP inhibits neuronal activity in the hippocampus
Willem, M., Tahirovic, S., Busche, M. A., Ovsepian, S. V., Chafai, M., Kootar, S., Hornburg, D., Evans, L. D. B., Moore, S., Daria, A., et al. (2015) · Nature · doi:10.1038/nature14864 · Cited by 398 · cited 3×
“Ah-a can reduce LTP (Willem et al., 2015). b-CTF mediates long-term synaptic plasticity deficits, behavioral deficits and neurodegeneration (Neve et al., 1996, Neve and Robakis, 1998, Oster-Granite et al., 1996, Tamayev et al., 2012b, 2012c).”
BackgroundLiu, Q., Zerbinatti, C. V., Zhang, J., Hoe, H.-S., Wang, B., Cole, S. L., Herz, J., Muglia, L., & Bu, G. (2007) · Neuron · doi:10.1016/j.neuron.2007.08.008 · Cited by 364
Synaptic vesicle recycling: steps and principles
Rizzoli, S. O. (2014) · The EMBO Journal · doi:10.1002/embj.201386357 · Cited by 317
Vidal, R., Révész, T., Rostagno, A., Kim, E., Holton, J. L., Bek, T., Bojsen-Møller, M., Braendgaard, H., Plant, G., Ghiso, J., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.080076097 · Cited by 300 · cited 2×
“A peptide encompassing this binding domain -named JCasp- is naturally produced by a g-secretase/caspase double-cut of APP.”
BackgroundWang, P., Yang, G., Mosier, D. R., Chang, P., Zaidi, T., Gong, Y.-D., Zhao, N.-M., Dominguez, B., Lee, K.-F., Gan, W.-B., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4660-04.2005 · Cited by 290
Synaptotagmin-1 functions as a Ca2+ sensor for spontaneous release
Xu, J., Pang, Z. P., Shin, O.-H., & Südhof, T. C. (2009) · Nature Neuroscience · doi:10.1038/nn.2320 · Cited by 274 · cited 1×
“Many of these proteins, such as cis- and trans-SNAREs, complexin, and the Ca2+ sensors synaptotagmins, function as key regulators of synaptic vesicles exocytosis (McMahon and Boucrot, 2011, Rizzoli, 2014, Royle and Lagnado, 2010, Südhof, 2012, 2013, Südhof and Rizo, 2011, Xu et al., 2009).”
BackgroundAmyloid beta peptides and glutamatergic synaptic dysregulation
Parameshwaran, K., Dhanasekaran, M., & Suppiramaniam, V. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2007.10.008 · Cited by 235
Tamayev, R., Matsuda, S., Arancio, O., & D'Adamio, L. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201100195 · Cited by 142
Self-citationMatsuda, S., Giliberto, L., Matsuda, Y., Davies, P., McGowan, E., Pickford, F., Ghiso, J., Frangione, B., & D'Adamio, L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500217200 · Cited by 141 · cited 1×
“…familial AD (FAD) and the AD-like familial British dementia and familial Danish dementia (De Strooper, 2007, De Strooper et al., 2010, De Strooper and Voet, 2012, Garringer et al., 2010, Matsuda et al., 2005, Giliberto et al., 2008, Matsuda et al., 2009, Tanzi, 2012, Vidal et al., 1999, 2000).”
BackgroundSelf-citationFogel, H., Frere, S., Segev, O., Bharill, S., Shapira, I., Gazit, N., O’Malley, T., Slomowitz, E., Berdichevsky, Y., Walsh, D. M., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.04.024 · Cited by 138 · cited 5×
“Finally, localization of APP at presynaptic terminals has been reported also in primary neuronal cultures where it can regulate synaptic transmission functioning as a presynaptic receptor for Ab (Fogel et al., 2014).”
BackgroundInfluentialTamayev, R., & D’Adamio, L. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-19 · Cited by 81
Self-citation
Cited by
Not just amyloid: physiological functions of the amyloid precursor protein family
Müller, U. C., Deller, T., & Korte, M. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.29 · Cited by 634
Behr, M., Sergeant, K., Leclercq, C. C., Planchon, S., Guignard, C., Lenouvel, A., Renaut, J., Hausman, J.-F., Lutts, S., & Guerriero, G. (2018) · BMC Plant Biology · doi:10.1186/s12870-017-1213-1 · Cited by 237
“NSAF = (100*SpC/MW)/Σ(SpC/MW)N, where SpC = Spectral Counts, MW= Protein molecular weight in Da and N = Total Number of Proteins [67].”
Modifications and Trafficking of APP in the Pathogenesis of Alzheimer’s Disease
Wang, X., Zhou, X., Li, G., Zhang, Y., Wu, Y., & Song, W. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00294 · Cited by 172
“APP plays numerous functions, such as neuronal differentiation, neurogenesis, synaptic function, apoptosis and cell proliferation (Bolós et al., 2014; Milosch et al., 2014; Fanutza et al., 2015; Wu et al., 2015, 2016).”
BackgroundHaure-Mirande, J.-V., Audrain, M., Fanutza, T., Kim, S. H., Klein, W. L., Glabe, C., Readhead, B., Dudley, J. T., Blitzer, R. D., Wang, M., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1737-3 · Cited by 127
“Coronal brain slices containing the hippocampal formation were prepared as previously described [17].”
MethodSelf-citationDel Prete, D., Rice, R. C., Rajadhyaksha, A. M., & D'Adamio, L. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.733626 · Cited by 86
“APP facilitates glutamatergic transmitter release, likely through the interaction with the neurotransmitter release machinery (28).”
BackgroundMethodInfluentialSelf-citation
Metadata
- Authors
- Fanutza, T., Del Prete, D., Ford, M. J., Castillo, P. E., & D’Adamio, L.
- Venue
- eLife
- Publisher
- eLife Sciences Publications, Ltd
- Published
- 2015-11-09
- Volume
- 4
- Pages
- e09743-e09743
- ISSN
- 2050-084X (ISSN-L)
- OpenAlex
- W2132219921
- Cited by
- 83
- References
- 29
- FWCI
- 4.30
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.